Abnormal expression patterns of WT1-as, MEG3 and ANRIL long non-coding RNAs in CD34+ cells from patients with primary myelofibrosis and their clinical correlations
Multiple myeloma (MM) is an hematological neoplasm characterized by uncontrolled clonal proliferatio...
International audienceClassical Philadelphia-negative myeloproliferative neoplasms include Polycythe...
Review on Myelofibrosis with myeloid metaplasia (MMM) - Idiopathic myelofibrosis - Agnogenic myeloid...
Abnormal expression patterns of WT1-as, MEG3 and ANRIL long non-coding RNAs in CD34+ cells from pati...
Long non-coding RNAs (lncRNAs) are emerging as key regulators of gene expression in normal and cance...
A growing body of evidence suggests that long non-coding RNAs (lncRNAs) are involved in the regulati...
This study was aimed at the characterization of a gene expression signature of the pluripotent hemat...
Monitoring patients with multiple myeloma during and after treatment for the presence of residual my...
Background: Myelodysplastic syndromes (MDS) are a group of clonal hematological disorders characteri...
To gain insight into the poorly understood pathophysiology of the myelodysplastic syndromes (MDSs), ...
To gain insight into the poorly understood pathophysiology of the myelodysplastic syndromes (MDSs), ...
Multiple myeloma (MM) is the second most common hematooncological disease of malignant plasma cells ...
Multiple myeloma (MM) is the most common form of plasma cell dyscrasia, characterized by a marked he...
Identifying a distinct gene signature for myelofibrosis may yield novel information of the genes, wh...
In normal bone marrow, WT1 expression is restricted to CD34+ cells. We assessed WT1 mRNA expression ...
Multiple myeloma (MM) is an hematological neoplasm characterized by uncontrolled clonal proliferatio...
International audienceClassical Philadelphia-negative myeloproliferative neoplasms include Polycythe...
Review on Myelofibrosis with myeloid metaplasia (MMM) - Idiopathic myelofibrosis - Agnogenic myeloid...
Abnormal expression patterns of WT1-as, MEG3 and ANRIL long non-coding RNAs in CD34+ cells from pati...
Long non-coding RNAs (lncRNAs) are emerging as key regulators of gene expression in normal and cance...
A growing body of evidence suggests that long non-coding RNAs (lncRNAs) are involved in the regulati...
This study was aimed at the characterization of a gene expression signature of the pluripotent hemat...
Monitoring patients with multiple myeloma during and after treatment for the presence of residual my...
Background: Myelodysplastic syndromes (MDS) are a group of clonal hematological disorders characteri...
To gain insight into the poorly understood pathophysiology of the myelodysplastic syndromes (MDSs), ...
To gain insight into the poorly understood pathophysiology of the myelodysplastic syndromes (MDSs), ...
Multiple myeloma (MM) is the second most common hematooncological disease of malignant plasma cells ...
Multiple myeloma (MM) is the most common form of plasma cell dyscrasia, characterized by a marked he...
Identifying a distinct gene signature for myelofibrosis may yield novel information of the genes, wh...
In normal bone marrow, WT1 expression is restricted to CD34+ cells. We assessed WT1 mRNA expression ...
Multiple myeloma (MM) is an hematological neoplasm characterized by uncontrolled clonal proliferatio...
International audienceClassical Philadelphia-negative myeloproliferative neoplasms include Polycythe...
Review on Myelofibrosis with myeloid metaplasia (MMM) - Idiopathic myelofibrosis - Agnogenic myeloid...